September 25, 2024 – AAEI recognizes members who lead the Association on key issues, initiatives, and projects. This week, AAEI spotlights Matt Guarrera of Vertex Pharmaceuticals.
Vertex Pharmaceuticals returned to AAEI this month. Matt and his manager Dan Muscato are excited to come back to the AAEI family and participate in the Healthcare Industries Committee.
Matt is Global Trade Compliance Director at Vertex Pharmaceuticals. Matt’s experience originates from the medical device industry in trade compliance, from which he has gained leadership experience managing global teams and complex logistics, customs, and trade operations in multiple countries. He specializes in international trade compliance, mergers and acquisitions, programs such as: C-TPAT, ISA, AEO, FCPA, EAR, ITAR, and he is also a licensed customs broker.
Matt also shares that he has two awesome teenage daughters—the youngest of whom is starting her first year at the University of Richmond in Virginia.
Matt thanks AAEI’s Vice Chair of Membership Matt Varner for “pulling him back into this exciting world of global trade compliance and all AAEI can do to change not just mindsets, but our government’s regulations, and improve how to better serve patients!”
Vertex Pharmaceuticals is a biotechnology company that focuses on medical innovation to treat serious diseases. Vertex produced the first medicines to target the cause of cystic fibrosis—a rare, life-threatening disease—Vertex continues to explore new areas by building a toolkit in cell and genetic therapies.
AAEI welcomes Matt back to the Association, as well as the rest of his colleagues at Vertex.
Together we make global trade happen.
